Arsenal Medical
Arsenal Medical is dedicated to transforming medical devices with innovative biomaterials. Founded by Carmichael Roberts, Robert Langer, and George Whitesides, the company aims to address unmet medical needs through thoughtfully designed products. Their vision is to provide local therapy for important medical conditions across various therapeutic areas, leveraging expertise in materials science and chemistry.
Arsenal Medical
100 Beaver Street, Suite 302, Waltham, MA 02453
Patents
Delivery system for in situ forming foams and methods of using the same
2020-06-23 • US-10687795-B2
View DetailsIn-Situ forming foam for the treatment of vascular dissections
2020-06-16 • US-10682436-B2
View DetailsWhat We Do
A rapidly expanding, hydrophobic foam designed for life-threatening trauma. It is intended to control hemorrhage in the abdomen, providing patients time to reach surgery. Recognized as a breakthrough device by the FDA.
An injectable, shear-responsive material that enables deep neurovascular occlusion. It is used for conditions like chronic subdural hematomas and hypervascular tumors, providing complete vascular occlusion.
Battlefield Resuscitation
Services
FDA Regulated Medical Devices
Key People
President & CEO
Chief Financial Officer
Chief Operating Officer
Executive Vice President, Clinical and Regulatory
Vice President, Quality
Vice President, Human Resources
News & Updates
Arsenal Medical Launches EMBO-02 Study for NeoCast™ to Assess Treatment of Chronic Subdural Hematoma
First patient enrolled in trial to evaluate safety and feasibility of innovative embolic agent in expanded patient population utilizing middle meningeal artery embolization (MMAe).
Data show NeoCast™ met primary endpoints and enabled significant distal penetration of hypervascular brain tumors.
NeoCast occluded approximately five times more vessel branches compared to the market-leading liquid embolic agent in swine kidneys.